Elan, the Dublin-based but US quoted drugs company has announced "promising" results from a Multiple Sclerosis drugs trail. Elan said on Saturday that that the results of clinical trails of Antegren were promising and "suggest that the agent mechanism of action has potential as a new approach to treating MS".
Elan trials favourable
Elan, the Dublin-based but US quoted drugs company has announced "promising" results from a Multiple Sclerosis drugs trail
IN THIS SECTION
FA Cup third-round draw: Holders Manchester United visit Arsenal
Seanad offers lifeboat to enable TDs who lost their seats remain in Oireachtas
High Court case seeks damages over State’s ‘systemic failure’ in providing secure settings for vulnerable children
The Irish Times view on events in Syria: pressure is building on Assad’s regime
Election 2024 results live updates: Cavan-Monaghan the last count still ongoing as speculation over next coalition grows
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning